Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius medical care deutschland gmbh - germania - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

Moldova - Kiromania - ANSA (Agenţia Naţională pentru Siguranţa Alimentelor)

ii catric Виктория - Диазинон - pisici

Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

monrol europe s.r.l. - romania - tc 99m - pertechnetate - generator de radionuclizi - 10-40 gbq - tiroida preparate pentru radiodiagnostic la nivelul tiroidei, varia

Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 2,5mg/ml - antitrombotice antiagregante plachetare

Romania - Kiromania - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 5mg/ml - antitrombotice antiagregante plachetare

Umoja wa Ulaya - Kiromania - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - gripa, umană - vaccinuri - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Moldova - Kiromania - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

novartis pharma ag - everolimus - comprimate - 2,5 mg

Romania - Kiromania - Ecolab

ecolab deutschland gmbh -

Romania - Kiromania - Ecolab

ecolab deutschland gmbh -

Umoja wa Ulaya - Kiromania - EMA (European Medicines Agency)

glaxosmithkline trading services - mepolizumab - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.